We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$312M
AUM Growth
+$21.7M
Cap. Flow
+$2.21M
Cap. Flow %
0.71%
Top 10 Hldgs %
30.51%
Holding
172
New
9
Increased
34
Reduced
71
Closed
2

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$2.2M
2
CAC icon
Camden National
CAC
+$1.72M
3
SNY icon
Sanofi
SNY
+$806K
4
QCOM icon
Qualcomm
QCOM
+$346K
5
IBM icon
IBM
IBM
+$299K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$717K
2
CRSP icon
CRISPR Therapeutics
CRSP
+$668K
3
AAPL icon
Apple
AAPL
+$666K
4
JPM icon
JPMorgan Chase
JPM
+$426K
5
INTC icon
Intel
INTC
+$394K

Sector Composition

Rank Sector Weight
1 Technology 21.57%
2 Healthcare 18.18%
3 Consumer Staples 13.78%
4 Industrials 11.86%
5 Financials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
26
Caterpillar
CAT
$398B
$3.69M 1.18%
24,769
-465
-2% -$65.3K
ITW icon
27
Illinois Tool Works
ITW
$83.2B
$3.67M 1.18%
18,986
-398
-2% -$75.6K
CVX icon
28
Chevron
CVX
$387B
$3.56M 1.14%
49,481
+860
+2% +$72.3K
MMM icon
29
3M
MMM
$94.7B
$3.54M 1.14%
26,453
-42
-0.2% -$5.65K
NVO
30
Novo Nordisk
NVO
$203B
$3.54M 1.13%
101,836
+65,978
+184% +$2.2M
WSO icon
31
Watsco Inc
WSO
$12.8B
$3.53M 1.13%
15,144
-688
-4% -$155K
GSK icon
32
GSK
GSK
$101B
$3.48M 1.12%
74,000
+2,984
+4% +$150K
ABBV icon
33
AbbVie
ABBV
$438B
$3.44M 1.1%
39,260
-175
-0.4% -$16.5K
PEP icon
34
PepsiCo
PEP
$189B
$3.42M 1.1%
24,680
+132
+0.5% +$18K
EL icon
35
Estee Lauder
EL
$31.9B
$3.41M 1.09%
15,607
-152
-1% -$31.3K
LMT icon
36
Lockheed Martin
LMT
$140B
$3.12M 1%
8,144
+115
+1% +$43.9K
TMO icon
37
Thermo Fisher Scientific
TMO
$222B
$2.88M 0.92%
6,533
-76
-1% -$31.4K
TJX icon
38
TJX Companies
TJX
$169B
$2.71M 0.87%
48,640
-425
-0.9% -$22.9K
AKAM icon
39
Akamai
AKAM
$17.8B
$2.69M 0.86%
24,291
+345
+1% +$38.3K
CRSP icon
40
CRISPR Therapeutics
CRSP
$5.21B
$2.63M 0.84%
31,430
-7,535
-19% -$668K
BAX icon
41
Baxter International
BAX
$14.1B
$2.57M 0.82%
31,985
-600
-2% -$50.5K
AWK icon
42
American Water Works
AWK
$26.8B
$2.57M 0.82%
17,710
-195
-1% -$27.6K
IBM icon
43
IBM
IBM
$221B
$2.38M 0.76%
20,459
+2,537
+14% +$299K
NVDA icon
44
NVIDIA
NVDA
$5.42T
$2.31M 0.74%
170,920
-3,600
-2% -$41.9K
NVS icon
45
Novartis
NVS
$290B
$2.31M 0.74%
26,563
-100
-0.4% -$8.66K
CAC icon
46
Camden National
CAC
$987M
$2.27M 0.73%
75,190
+53,210
+242% +$1.72M
CB icon
47
Chubb
CB
$133B
$2.27M 0.73%
19,555
-85
-0.4% -$10.7K
DUK icon
48
Duke Energy
DUK
$96.4B
$2.21M 0.71%
24,956
-225
-0.9% -$18.5K
MCD icon
49
McDonald's
MCD
$195B
$2.17M 0.69%
9,871
-150
-1% -$30.8K
NKE icon
50
Nike
NKE
$60.4B
$2.05M 0.66%
16,301
-347
-2% -$37.3K

Similar funds

Ipswich Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Ipswich Investment Management held 172 positions worth $312M, up 7.5% from $290M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ipswich Investment Management's Q3 2020 filing shows 9 new, 34 increased, 71 reduced and 2 closed positions. Its largest new stake was Sanofi: 15,655 shares worth $785K. The largest sale was Microsoft, an estimated $717K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Ipswich Investment Management's largest Q3 2020 buy was Sanofi: 15,655 shares worth $785K.
  • Ipswich Investment Management added most to Novo Nordisk in Q3 2020, an estimated $2.2M increase.
  • Ipswich Investment Management's biggest Q3 2020 reduction was Microsoft, cutting an estimated $717K.
  • Ipswich Investment Management fully exited Phillips 66 in Q3 2020, selling an estimated $236K.
  • Ipswich Investment Management's ten largest holdings make up 31% of its $312M portfolio in Q3 2020.
  • Ipswich Investment Management opened 9 new positions and closed 2 in Q3 2020.
  • Ipswich Investment Management's portfolio value rose 7.5% quarter-over-quarter to $312M.

Based on Ipswich Investment Management's 13F filing for Q3 2020, filed 6 Oct 2020.